Startle Response in Progressive Myoclonic Epilepsy

被引:7
作者
Kiziltan, Meral E. [1 ]
Gunduz, Aysegul [1 ]
Coskun, Tulin [1 ]
Delil, Sakir [1 ]
Pazarci, Nevin [1 ]
Ozkara, Cigdem [1 ]
Yeni, Naz [1 ]
机构
[1] Istanbul Univ, Cerrahpasa Med Sch, Istanbul, Turkey
关键词
progressive myoclonic epilepsy; Lafora disease; neuronal ceroid lipofuscinosis; Unverricht-Lundborg disease; auditory startle response; startle response to somatosensory stimuli; UNVERRICHT-LUNDBORG-DISEASE; PREPULSE INHIBITION; EXCITABILITY; VALPROATE; DEFICITS; MRI;
D O I
10.1177/1550059416646292
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cortical reflex myoclonus is a typical feature of progressive myoclonic epilepsy (PME) in which it is accompanied by other types of mostly drug-resistant seizures and progressive neurological signs. Although PME is characterized by cortical hyperexcitability, studies have demonstrated atrophy and degenerative changes in the brainstem in various types of PME. Thus, we have questioned whether any stimuli may trigger a hyperactive response of brainstem reticular formation in PME and investigated the startle reflex in individuals with PME. We recorded the auditory startle response (ASR) and the startle response to somatosensory inputs (SSS) in patients with PME, and compared the results with healthy volunteers and patients with other types of drug-resistant epilepsy. All patients were using antiepileptic drugs (AEDs), 12 were on multiple AEDs. The probability of ASR was significantly lower and mean onset latency was longer in patients with PME compared with other groups. SSS responses over all muscles were low in both the PME and drug-resistant epilepsy groups; however, the differences were not statistically significant. The presence of a response over the biceps brachii muscle was zero in the PME group and showed a borderline difference compared with the other groups. Decreased probability and prolonged latencies of ASR in PME indicate inhibition of reflex circuit. A trend for decreased responses of SSS suggests hypoactive SSS in both PME and other epilepsy groups. Hypoactive ASR in PME and hypoactive SSS in both PME and other epilepsies may be attributed to the degeneration of pontine reticular nuclei in PME and functional inhibition by AEDs in both disorders.
引用
收藏
页码:123 / 129
页数:7
相关论文
共 50 条
  • [31] The Roles of Cystatin B in the Brain and Pathophysiological Mechanisms of Progressive Myoclonic Epilepsy Type 1
    Singh, Shekhar
    Hamalainen, Riikka H.
    CELLS, 2024, 13 (02)
  • [32] Genetic profile of progressive myoclonic epilepsy in Mali reveals novel findings
    Cisse, Lassana
    Bamba, Salia
    Diallo, Seybou H.
    Ji, Weizhen
    Dembele, Mohamed Emile
    Yalcouye, Abdoulaye
    Coulibaly, Toumany
    Traore, Ibrahima
    Jeffries, Lauren
    Diarra, Salimata
    Maiga, Alassane Dit Baneye
    Diallo, Salimata
    Nimaga, Karamoko
    Toure, Amadou
    Traore, Oumou
    Kotioumbe, Mahamadou
    Mis, Emily Kathryn
    Cisse, Cheick Abdel Kader
    Guinto, Cheick Oumar
    Fischbeck, Kenneth H.
    Khokha, Mustafa K.
    Lakhani, Saquib A.
    Landoure, Guida
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [33] Sustained seizure remission on perampanel in progressive myoclonic epilepsy (Lafora disease)
    Schorlemmer, Kathrin
    Bauer, Sebastian
    Belke, Marcus
    Hermsen, Anke
    Klein, karl Martin
    Reif, Philipp S.
    Oertel, Wolfgang H.
    Kunz, Wolfram S.
    Knake, Susanne
    Rosenow, Felix
    Strzelczyk, Adam
    EPILEPSY & BEHAVIOR CASE REPORTS, 2013, 1 : 118 - 121
  • [34] KCTD7-related progressive myoclonic epilepsy: Report of 42 cases and review of literature
    Yoganathan, Sangeetha
    Whitney, Robyn
    Thomas, Maya
    Danda, Sumita
    Chettali, Akbar Mohamed
    Prasad, Asuri N.
    Farhan, Sali M. K.
    Alsowat, Daad
    Abukhaled, Musaad
    Aldhalaan, Hesham
    Gowda, Vykuntaraju K.
    Kinhal, Uddhava V.
    Bylappa, Arun Y.
    Konanki, Ramesh
    Lingappa, Lokesh
    Parchuri, Bindu Madhavi
    Appendino, Juan P.
    Scantlebury, Morris H.
    Cunningham, Jessie
    Hadjinicolaou, Aristides
    El Achkar, Christelle Moufawad
    Kamate, Mahesh
    Menon, Ramshekhar N.
    Jose, Manna
    Riordan, Gillian
    Kannan, Lakshminarayanan
    Jain, Vivek
    Manokaran, Ranjith Kumar
    Chau, Vann
    Donner, Elizabeth J.
    Costain, Gregory
    Minassian, Berge A.
    Jain, Puneet
    EPILEPSIA, 2024, 65 (03) : 709 - 724
  • [35] Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK): a cause of progressive myoclonic epilepsy
    Rohan R. Mahale
    Ravindu Tiwari
    Gautham Arunachal
    Hansashree Padmanabha
    Pooja Mailankody
    Acta Neurologica Belgica, 2022, 122 : 801 - 803
  • [36] Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK): a cause of progressive myoclonic epilepsy
    Mahale, Rohan R.
    Tiwari, Ravindu
    Arunachal, Gautham
    Padmanabha, Hansashree
    Mailankody, Pooja
    ACTA NEUROLOGICA BELGICA, 2022, 122 (03) : 801 - 803
  • [37] Differences in evoked potential characteristics between DRPLA patients and patients with progressive myoclonic epilepsy: preliminary findings indicating usefulness for differential diagnosis
    Kasai, K
    Onuma, T
    Kato, M
    Kato, T
    Takeya, J
    Sekimoto, M
    Watanabe, K
    Minami, N
    Goto, Y
    Minabe, Y
    EPILEPSY RESEARCH, 1999, 37 (01) : 3 - 11
  • [38] Early-Onset Progressive Myoclonic Epilepsy With Dystonia Mapping to 16pter-p13.3
    Duru, Nadire
    Iseri, Sibel Aylin Ugur
    Selcuk, Nilgun
    Tolun, Aslihan
    JOURNAL OF NEUROGENETICS, 2010, 24 (04) : 207 - 215
  • [39] Metreleptin for the treatment of progressive encephalopathy with/without lipodystrophy (PELD) in a child with progressive myoclonic epilepsy: a case report
    Stefania Pedicelli
    Luca de Palma
    Caterina Pelosini
    Marco Cappa
    Italian Journal of Pediatrics, 46
  • [40] Can changes in cortical excitability distinguish progressive from juvenile myoclonic epilepsy?
    Badawy, Radwa A. B.
    Macdonell, Richard A. L.
    Jackson, Graeme D.
    Berkovic, Samuel F.
    EPILEPSIA, 2010, 51 (10) : 2084 - 2088